North America's e-Cigarette Market Set to Explode at 18.2% CAGR, Reaching $31.3 Billion by 2028 - Market Shares by Product Type, Flavor Variation, Battery Operation Mode, and Distribution Channel Unveiled
31 janv. 2024 03h59 HE
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "North America e-Cigarette Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Global E-Cigarette Markets, 2021-2022 & 2027: Shift towards Next Generation Products, Upswing in Gen Z Income, Rise in Technological Developments
13 sept. 2022 05h33 HE
|
Research and Markets
Dublin, Sept. 13, 2022 (GLOBE NEWSWIRE) -- The "Global E-Cigarette Market: By Product Type, By Category, By Composition, By Distribution Channel, By Region Size & Forecast with Impact Analysis...
Insights on the E-Cigarette Global Market to 2027 - by Product, Flavor, Mode of Operation, Distribution Channel and Region
06 avr. 2022 07h58 HE
|
Research and Markets
Dublin, April 06, 2022 (GLOBE NEWSWIRE) -- The "E-Cigarette Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's...
Global E-Cigarette Market Report 2021: Consumer Perception of a Safer Product v Traditional Cigarettes has Led to Increased Demand
22 avr. 2021 07h48 HE
|
Research and Markets
Dublin, April 22, 2021 (GLOBE NEWSWIRE) -- The "E-Cigarette Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's...
Rapid Therapeutic Announces Completion of New ISO 13485 Laboratory
18 août 2020 07h00 HE
|
Rapid Therapeutic Science Laboratories
DALLAS, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on...
Rapid Therapeutic Science Laboratories (RTSL), Inc. engages Ezzey Digital Marketing Agency to Launch its New Lifestyle Brand “nhāler”
06 août 2020 07h00 HE
|
Rapid Therapeutic Science Laboratories
DALLAS, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL), an SEC fully-reporting, growth-oriented manufacturing and marketing company focused on employing...
Rapid Therapeutic Completes Delivery of Additional 6,000 Units of its Proprietary Metered Dose Inhalers
14 juil. 2020 07h30 HE
|
Rapid Therapeutic Science Laboratories, Inc. (OTC:RTSL)
DALLAS, July 14, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented manufacturing and marketing company focused on employing...
Rapid Therapeutic Announces Major Contract is Increased by 150% to 250,000 Metered Dose Inhalers
09 juil. 2020 07h30 HE
|
Rapid Therapeutic Science Laboratories, Inc. (OTC:RTSL)
DALLAS, July 09, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL), a fully-reporting, early stage, emerging biotech company focused on aerosol delivery of...
Rapid Therapeutic Completes Initial Delivery of 2,000 Units of its Proprietary Metered Dose Inhalers
08 juil. 2020 07h30 HE
|
Rapid Therapeutic Science Laboratories, Inc. (OTC:RTSL)
DALLAS, July 08, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented company focused on manufacturing and marketing aerosol...
Rapid Therapeutic Science Laboratories, Inc. Highlighted in Research Report Released by Emerald Equity Research, LLC
22 juin 2020 08h30 HE
|
Rapid Therapeutic Science Laboratories
DALLAS, June 22, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented company focused on manufacturing and marketing CBD aerosol...